Carl Zeiss Vision International announced the completion of its acquisition of Brighten Optix, a provider of orthokeratology and specialty contact lenses. 

Brighten Optix products are available and used by eye care professionals and eye clinics in Greater China and across Southeast Asia. Zeiss said the acquisition, announced in June 2025, marks a milestone in the company's mission to protect and enhance lifelong visual health for consumers around the world. By bringing Brighten Optix into its network, Zeiss said it aims to accelerate the development and delivery of technologies that support eye health from an early age.

"We are excited to officially welcome Brighten Optix and their talented teams to the Zeiss family," said Sven Hermann, CEO Zeiss Consumer Markets. "This acquisition not only reinforces our commitment to innovation and excellence in the field of vision care and visual health but also enhances our product offerings. We are bundling our forces to tackle the global burden of myopia."

"With Brighten Optix' rich history in research and development and the strong portfolio we have built in the last 50 years, we now eagerly anticipate the new opportunities that lie ahead with Zeiss Vision Care," said Richard Wu, General Manager of Brighten Optix. "By combining our strengths, we can expand our capabilities, and drive advancements to improve and protect vision more effectively than ever before. I am immensely proud of the Brighten Optix team and excited about the journey that lies ahead of us all, becoming an integral part of Zeiss Vision Care."

Zeiss said the integration efforts will begin immediately.